Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription Articles published in J Immunol Retrieve available abstracts of 64 articles: HTML format

Single Articles

November 2024
1. TONG X, Deng Y, Cizmeci D, Fontana L, et al
   Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
   J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
   PubMed     Abstract available
   
   
   March 2024
2. AL-AHMAD A
   Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
   J Immunol. 2024;212:753.
   PubMed    
   
   
   January 2024
3. PULLEN RH 3RD, Sassano E, Agrawal P, Escobar J, et al
   A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human Innate Immunity Assay System.
   J Immunol. 2024 Jan 26:ji2300185. doi: 10.4049/jimmunol.2300185.
   PubMed     Abstract available
   
   
   
4. AUNG A, Irvine DJ
   Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines.
   J Immunol. 2024;212:171-178.
   PubMed     Abstract available
   
   
   
5. SOBRAL MC, Mooney DJ
   Materials-Based Approaches for Cancer Vaccination.
   J Immunol. 2024;212:179-187.
   PubMed     Abstract available
   
   
   
6. ZHENG YY, Zhao L, Wei XF, Sun TZ, et al
   Vaccine Molecule Design Based on Phage Display and Computational Modeling against Rhabdovirus.
   J Immunol. 2024 Jan 10:ji2300447. doi: 10.4049/jimmunol.2300447.
   PubMed     Abstract available
   
   
   
7. HORTA AL, Gigley J, Boutet M, Lavau G, et al
   Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection.
   J Immunol. 2024 Jan 10:ji2300509. doi: 10.4049/jimmunol.2300509.
   PubMed     Abstract available
   
   
   December 2023
8. PEIL J, Vossen C, Bock F, Clahsen T, et al
   Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
   J Immunol. 2023 Dec 15:ji2300063. doi: 10.4049/jimmunol.2300063.
   PubMed     Abstract available
   
   
   November 2023
9. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
   Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
   J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
   PubMed     Abstract available
   
   
   
10. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    PubMed     Abstract available
    
    
    October 2023
11. KING HAD, Pokkali S, Kim D, Brammer D, et al
    Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques.
    J Immunol. 2023 Oct 20:ji2300424. doi: 10.4049/jimmunol.2300424.
    PubMed     Abstract available
    
    
    
12. JOHNSON AMF, Hager K, Alameh MG, Van P, et al
    The Regulation of Nucleic Acid Vaccine Responses by the Microbiome.
    J Immunol. 2023 Oct 18:ji2300196. doi: 10.4049/jimmunol.2300196.
    PubMed     Abstract available
    
    
    
13. CHEN T, Guo J, Yang M, Zhu X, et al
    Expression of Concern: Chemokine-Containing Exosomes Are Released From Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine.
    J Immunol. 2023;211:1250.
    PubMed    
    
    
    
14. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    PubMed     Abstract available
    
    
    September 2023
15. DE ARAUJO ACVSC, de Queiroz NMGP, Marinho FV, Oliveira SC, et al
    Bacillus Calmette-Guerin-Trained Macrophages Elicit a Protective Inflammatory Response against the Pathogenic Bacteria Brucella abortus.
    J Immunol. 2023;211:791-803.
    PubMed     Abstract available
    
    
    August 2023
16. ZHANG R, Tang L, Wang Y, Li Q, et al
    alpha-d-Glucose-1,6-Biphosphate Induces Dendritic Cell Homing to Enhance the Antitumor Effect of Neoantigen Vaccines.
    J Immunol. 2023 Aug 9:ji2200687. doi: 10.4049/jimmunol.2200687.
    PubMed     Abstract available
    
    
    July 2023
17. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    PubMed     Abstract available
    
    
    June 2023
18. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    PubMed     Abstract available
    
    
    
19. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    PubMed     Abstract available
    
    
    
20. ZHANG Y, Hardy LC, Kapita CM, Hall JA, et al
    Intestinal Helminth Infection Impairs Oral and Parenteral Vaccine Efficacy.
    J Immunol. 2023 Jun 5:ji2300084. doi: 10.4049/jimmunol.2300084.
    PubMed     Abstract available
    
    
    May 2023
21. VINCENT BG, File DM, McKinnon KP, Moore DT, et al
    Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
    J Immunol. 2023 May 19:ji2300077. doi: 10.4049/jimmunol.2300077.
    PubMed     Abstract available
    
    
    April 2023
22. WANG H, Clapp B, Hoffman C, Yang X, et al
    A Single Nasal Dose Vaccination with a Brucella abortus Mutant Potently Protects against Pulmonary Infection.
    J Immunol. 2023 Apr 10:ji2300071. doi: 10.4049/jimmunol.2300071.
    PubMed     Abstract available
    
    
    March 2023
23. ALAM MM, Gower T, Jiang M, Oppenheim JJ, et al
    A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice.
    J Immunol. 2023 Mar 22:ji2200371. doi: 10.4049/jimmunol.2200371.
    PubMed     Abstract available
    
    
    
24. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    PubMed     Abstract available
    
    
    
25. CROUSE B, Baehr C, Hicks D, Pravetoni M, et al
    IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice.
    J Immunol. 2023 Mar 20:ji2200605. doi: 10.4049/jimmunol.2200605.
    PubMed     Abstract available
    
    
    
26. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    PubMed     Abstract available
    
    
    February 2023
27. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    PubMed     Abstract available
    
    
    
28. SACKETT K, Brown P, Dutta K, Scully IL, et al
    Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine Immunogenicity.
    J Immunol. 2023 Feb 1:ji2100849. doi: 10.4049/jimmunol.2100849.
    PubMed     Abstract available
    
    
    January 2023
29. NG T, Flores-Malavet V, Mansoor MAM, Arvelo AC, et al
    Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza.
    J Immunol. 2023 Jan 16:ji2200393. doi: 10.4049/jimmunol.2200393.
    PubMed     Abstract available
    
    
    
30. GINGERICH AD, Royer F, McCormick AL, Scasny A, et al
    Synergistic Protection against Secondary Pneumococcal Infection by Human Monoclonal Antibodies Targeting Distinct Epitopes.
    J Immunol. 2023;210:50-60.
    PubMed     Abstract available
    
    
    December 2022
31. SINGH AK, Majumder S, Wang X, Song R, et al
    Lung Resident Memory T Cells Activated by Oral Vaccination Afford Comprehensive Protection against Pneumonic Yersinia pestis Infection.
    J Immunol. 2022 Dec 7:ji2200487. doi: 10.4049/jimmunol.2200487.
    PubMed     Abstract available
    
    
    
32. MISE-OMATA S, Ikeda M, Takeshita M, Uwamino Y, et al
    Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.
    J Immunol. 2022;209:2104-2113.
    PubMed     Abstract available
    
    
    November 2022
33. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022;209:1832-1836.
    PubMed     Abstract available
    
    
    
34. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022;209:1892-1905.
    PubMed     Abstract available
    
    
    
35. LOBBY JL, Uddback I, Scharer CD, Mi T, et al
    Persistent Antigen Harbored by Alveolar Macrophages Enhances the Maintenance of Lung-Resident Memory CD8(+) T Cells.
    J Immunol. 2022;209:1778-1787.
    PubMed     Abstract available
    
    
    October 2022
36. MISE-OMATA S, Ikeda M, Takeshita M, Uwamino Y, et al
    Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.
    J Immunol. 2022 Oct 14. pii: jimmunol.2200525. doi: 10.4049/jimmunol.2200525.
    PubMed     Abstract available
    
    
    
37. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8(+) T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022 Oct 5. pii: jimmunol.2200577. doi: 10.4049/jimmunol.2200577.
    PubMed     Abstract available
    
    
    September 2022
38. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022 Sep 28. pii: jimmunol.2200369. doi: 10.4049/jimmunol.2200369.
    PubMed     Abstract available
    
    
    July 2022
39. COHEN KW, Tian Y, Thayer C, Seese A, et al
    Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4(+) T Cells That Correlated with Reduced Risk of Infection in RV144 Trial.
    J Immunol. 2022 Jul 8. pii: jimmunol.2101211. doi: 10.4049/jimmunol.2101211.
    PubMed     Abstract available
    
    
    
40. VENKATASUBRAMANIAN S, Pryor R, Plumlee C, Cohen SB, et al
    TOLLIP Optimizes Dendritic Cell Maturation to Lipopolysaccharide and Mycobacterium tuberculosis.
    J Immunol. 2022 Jul 8. pii: jimmunol.2200030. doi: 10.4049/jimmunol.2200030.
    PubMed     Abstract available
    
    
    June 2022
41. CUSIMANO GM, Gary EN, Bell MR, Warner BM, et al
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
    PubMed     Abstract available
    
    
    
42. NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
    The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
    J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
    PubMed     Abstract available
    
    
    
43. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    PubMed     Abstract available
    
    
    
44. KRMESKA V, Aggio JB, Nylen S, Wowk PF, et al
    Cyclooxygenase-Derived Prostaglandin E2 Drives IL-1-Independent Mycobacterium bovis Bacille Calmette-Guerin-Triggered Skin Dendritic Cell Migration to Draining Lymph Node.
    J Immunol. 2022;208:2549-2557.
    PubMed     Abstract available
    
    
    May 2022
45. RICHERT L, Lelievre JD, Lacabaratz C, Hardel L, et al
    T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.
    J Immunol. 2022 May 25. pii: jimmunol.2101076. doi: 10.4049/jimmunol.2101076.
    PubMed     Abstract available
    
    
    April 2022
46. SOMIYA M
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2022;208:1833.
    PubMed    
    
    
    
47. BANSAL S, Fleming T, Mohanakumar T
    Response to Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2022;208:1833-1834.
    PubMed    
    
    
    March 2022
48. DHUME K, Finn CM, Devarajan P, Singh A, et al
    Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
    J Immunol. 2022 Mar 25. pii: jimmunol.2100801. doi: 10.4049/jimmunol.2100801.
    PubMed     Abstract available
    
    
    
49. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    PubMed     Abstract available
    
    
    
50. ROBERTS LM, Wehrly TD, Leighton I, Hanley P, et al
    Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent Francisella tularensis.
    J Immunol. 2022;208:1180-1188.
    PubMed     Abstract available
    
    
    February 2022
51. KOHN EM, Dos Santos Dias L, Dobson HE, He X, et al
    SLAMF1 Is Dispensable for Vaccine-Induced T Cell Development but Required for Resistance to Fungal Infection.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100819. doi: 10.4049/jimmunol.2100819.
    PubMed     Abstract available
    
    
    
52. QIN Y, Teng Q, Feng D, Pei Y, et al
    Development of a Nanoparticle Multiepitope DNA Vaccine against Virulent Infectious Bronchitis Virus Challenge.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100909. doi: 10.4049/jimmunol.2100909.
    PubMed     Abstract available
    
    
    
53. SHAH JA, Warr AJ, Graustein AD, Saha A, et al
    REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100671. doi: 10.4049/jimmunol.2100671.
    PubMed     Abstract available
    
    
    
54. DWIVEDI V, Gautam S, Headley CA, Piergallini T, et al
    IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette-Guerin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice.
    J Immunol. 2022 Feb 18. pii: jimmunol.2100900. doi: 10.4049/jimmunol.2100900.
    PubMed     Abstract available
    
    
    
55. MEYER-ARNDT L, Schwarz T, Loyal L, Henze L, et al
    Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4(+) T Cells following BNT162b2 Vaccination in the Elderly.
    J Immunol. 2022 Feb 4. pii: jimmunol.2100990. doi: 10.4049/jimmunol.2100990.
    PubMed     Abstract available
    
    
    
56. NICOLI F, Cabral-Piccin MP, Papagno L, Gallerani E, et al
    Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8(+) T Cells in Elderly Humans.
    J Immunol. 2022;208:562-570.
    PubMed     Abstract available
    
    
    January 2022
57. KOMISSAROV AA, Dolzhikova IV, Efimov GA, Logunov DY, et al
    Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
    J Immunol. 2022 Jan 31. pii: jimmunol.2101052. doi: 10.4049/jimmunol.2101052.
    PubMed     Abstract available
    
    
    
58. TU MK, Chiang SH, Bender RA, Wong DTW, et al
    The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100919. doi: 10.4049/jimmunol.2100919.
    PubMed     Abstract available
    
    
    December 2021
59. JONG RM, Van Dis E, Berry SB, Nguyenla X, et al
    Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.
    J Immunol. 2021 Dec 29. pii: jimmunol.2100029. doi: 10.4049/jimmunol.2100029.
    PubMed     Abstract available
    
    
    November 2021
60. HINKLE L, Liu Y, Meng C, Chen Z, et al
    The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.
    J Immunol. 2021 Nov 12. pii: jimmunol.2100719. doi: 10.4049/jimmunol.2100719.
    PubMed     Abstract available
    
    
    
61. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    PubMed     Abstract available
    
    
    October 2021
62. LEFEBVRE MN, Drewry LL, Pewe LL, Hancox LS, et al
    Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites.
    J Immunol. 2021 Oct 29. pii: jimmunol.2100818. doi: 10.4049/jimmunol.2100818.
    PubMed     Abstract available
    
    
    
63. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    PubMed     Abstract available
    
    
    
64. SPURRIER MA, Jennings-Gee JE, Daly CA, Haas KM, et al
    The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.
    J Immunol. 2021;207:1978-1989.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.